Schoolgirls reporting adverse effects from cervical cancer vaccine

The Irish Medicines Board says it has received 64 reports of adverse affects associated with the use of Gardasil.

Thu, 11 Nov, 2010 - 19:35

The Irish Medicines Board says it has received 64 reports of adverse affects associated with the use of Gardasil.

The vaccine is being administered to secondary school students to protect against cervical cancer.

You have reached your article limit. Already a subscriber? Sign in

Unlimited access starts here.

Try from only €0.25 a day.

Cancel anytime

CONNECT WITH US TODAY

Whatsapp logo

WHATSAPP

Newsletter logo

NEWSLETTERS

Notification logo

NOTIFICATIONS

Be the first to know the latest news and updates

More in this section

Yves Sakila's body returned to family as investigations into Dublin death continue Yves Sakila's body returned to family as investigations into Dublin death continue
Stephen McCullagh court case Stephen McCullagh to appeal 31-year sentence for murder of Natalie McNally
Covid-19 pandemic inquiry Sinn Féin calls on Stormont Speaker to step aside over Donaldson concerns
CourtsCervical cancer vaccineOrganisation: Irish Medicines BoardOrganisation: HPV Schools Immunisation ProgrammeOrganisation: IMBOrganisation: Medicines Board
<p lang="EN-GB" paraeid="{fdb37f6a-8d3d-4ebe-8d7f-41630234bdc5}{202}" paraid="179238633"> <span data-contrast="none" lang="EN-GB" xml:lang="EN-GB">The briefing heard that a telltale sign AI is being used to compose complaints is when members of the public copy the entirety of the response returned from a portal into the complaint form - including the prompt or question they entered into the engine in the first place, or the chatbot’s follow-up responses. File picture</span> </p>

Surge in complaints to Data Protection Commission as people use AI to compile submissions 

READ NOW

Lunchtime News

Newsletter

Get a lunch briefing straight to your inbox at noon daily. Also be the first to know with our occasional Breaking News emails.

Latest

Most Read

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited